Influenza A Reduction


Vivienne Mahon, Science & Quality Manager


Airmid Health Group Ltd.


Full Report


To evaluate the efficacy of the NV1050 on removing Influenza A.


Testing of the NV1050 was conducted in a 28.5 menvironmental test chamber. The chamber was preconditioned to 20±3ºC and 50±10% relative humidity prior to commencement of the tests. For the test runs, the NV1050 was placed on the floor in the centre of the chamber.

Summary of Results

The NV1050 was effective in reducing airborne Influenza A aerosols in the test chamber, reaching 99.9% airborne virus reduction within the first 10 – 20 minutes of operation at max speed.